262 related articles for article (PubMed ID: 19755855)
21. Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1.
Hayashi Y; Bardsley MR; Toyomasu Y; Milosavljevic S; Gajdos GB; Choi KM; Reid-Lombardo KM; Kendrick ML; Bingener-Casey J; Tang CM; Sicklick JK; Gibbons SJ; Farrugia G; Taguchi T; Gupta A; Rubin BP; Fletcher JA; Ramachandran A; Ordog T
Gastroenterology; 2015 Aug; 149(2):420-32.e16. PubMed ID: 25865047
[TBL] [Abstract][Full Text] [Related]
22. An Activating KIT Mutation Induces Crizotinib Resistance in ROS1-Positive Lung Cancer.
Dziadziuszko R; Le AT; Wrona A; Jassem J; Camidge DR; Varella-Garcia M; Aisner DL; Doebele RC
J Thorac Oncol; 2016 Aug; 11(8):1273-1281. PubMed ID: 27068398
[TBL] [Abstract][Full Text] [Related]
23. High resolution analysis of non-small cell lung cancer cell lines by whole genome tiling path array CGH.
Garnis C; Lockwood WW; Vucic E; Ge Y; Girard L; Minna JD; Gazdar AF; Lam S; MacAulay C; Lam WL
Int J Cancer; 2006 Mar; 118(6):1556-64. PubMed ID: 16187286
[TBL] [Abstract][Full Text] [Related]
24. Loss of 4q21.23-22.1 is a prognostic marker for disease free and overall survival in non-small cell lung cancer.
Uzunoglu FG; Dethlefsen E; Hanssen A; Wrage M; Deutsch L; Harms-Effenberger K; Vashist YK; Reeh M; Sauter G; Simon R; Bockhorn M; Pantel K; Izbicki JR; Wikman H
PLoS One; 2014; 9(12):e113315. PubMed ID: 25501003
[TBL] [Abstract][Full Text] [Related]
25. Co-active receptor tyrosine kinases mitigate the effect of FGFR inhibitors in FGFR1-amplified lung cancers with low FGFR1 protein expression.
Kotani H; Ebi H; Kitai H; Nanjo S; Kita K; Huynh TG; Ooi A; Faber AC; Mino-Kenudson M; Yano S
Oncogene; 2016 Jul; 35(27):3587-97. PubMed ID: 26549034
[TBL] [Abstract][Full Text] [Related]
26. KIT overexpression and amplification in gastrointestinal stromal tumors (GISTs).
Tabone S; Théou N; Wozniak A; Saffroy R; Deville L; Julié C; Callard P; Lavergne-Slove A; Debiec-Rychter M; Lemoine A; Emile JF
Biochim Biophys Acta; 2005 Jun; 1741(1-2):165-72. PubMed ID: 15869870
[TBL] [Abstract][Full Text] [Related]
27. Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization.
Luk C; Tsao MS; Bayani J; Shepherd F; Squire JA
Cancer Genet Cytogenet; 2001 Mar; 125(2):87-99. PubMed ID: 11369051
[TBL] [Abstract][Full Text] [Related]
28. High density DNA array analysis reveals distinct genomic profiles in a subset of gastrointestinal stromal tumors.
Belinsky MG; Skorobogatko YV; Rink L; Pei J; Cai KQ; Vanderveer LA; Riddell D; Merkel E; Tarn C; Eisenberg BL; von Mehren M; Testa JR; Godwin AK
Genes Chromosomes Cancer; 2009 Oct; 48(10):886-96. PubMed ID: 19585585
[TBL] [Abstract][Full Text] [Related]
29. The oncogenic role of PKCiota gene amplification and overexpression in Chinese non-small cell lung cancer.
Luo Q; Tang L; Lin H; Huang J; Zhang T; Liu Y; Wang J; Zhan P; Yin X; Su X; Ji Q; Yu D; Xu L
Lung Cancer; 2014 May; 84(2):190-5. PubMed ID: 24636699
[TBL] [Abstract][Full Text] [Related]
30. FIP1L1-PDGFRalpha alone or with other genetic abnormalities reveals disease progression in chronic eosinophilic leukemia but good response to imatinib.
Wang LN; Pan Q; Fu JF; Shi JY; Jin J; Li JM; Hu J; Zhao WL; Chen Z; Chen SJ
Chin Med J (Engl); 2008 May; 121(10):867-73. PubMed ID: 18706197
[TBL] [Abstract][Full Text] [Related]
31. Chromosome copy number changes carry prognostic information independent of KIT/PDGFRA point mutations in gastrointestinal stromal tumors.
Silva M; Veiga I; Ribeiro FR; Vieira J; Pinto C; Pinheiro M; Mesquita B; Santos C; Soares M; Dinis J; Santos L; Lopes P; Afonso M; Lopes C; Teixeira MR
BMC Med; 2010 May; 8():26. PubMed ID: 20470368
[TBL] [Abstract][Full Text] [Related]
32. Genomic profiles associated with early micrometastasis in lung cancer: relevance of 4q deletion.
Wrage M; Ruosaari S; Eijk PP; Kaifi JT; Hollmén J; Yekebas EF; Izbicki JR; Brakenhoff RH; Streichert T; Riethdorf S; Glatzel M; Ylstra B; Pantel K; Wikman H
Clin Cancer Res; 2009 Mar; 15(5):1566-74. PubMed ID: 19208797
[TBL] [Abstract][Full Text] [Related]
33. Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer.
Dutt A; Ramos AH; Hammerman PS; Mermel C; Cho J; Sharifnia T; Chande A; Tanaka KE; Stransky N; Greulich H; Gray NS; Meyerson M
PLoS One; 2011; 6(6):e20351. PubMed ID: 21666749
[TBL] [Abstract][Full Text] [Related]
34. Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas: Comparison of four commercially available antibodies by immunohistochemistry and fluorescence in situ hybridization study.
Lee HJ; Xu X; Choe G; Chung DH; Seo JW; Lee JH; Lee CT; Jheon S; Sung SW; Chung JH
Lung Cancer; 2010 Jun; 68(3):375-82. PubMed ID: 19712993
[TBL] [Abstract][Full Text] [Related]
35. BCL2L2 is a probable target for novel 14q11.2 amplification detected in a non-small cell lung cancer cell line.
Kawasaki T; Yokoi S; Tsuda H; Izumi H; Kozaki K; Aida S; Ozeki Y; Yoshizawa Y; Imoto I; Inazawa J
Cancer Sci; 2007 Jul; 98(7):1070-7. PubMed ID: 17459056
[TBL] [Abstract][Full Text] [Related]
36. The hypereosinophilic syndrome: fluorescence in situ hybridization detects the del(4)(q12)-FIP1L1/PDGFRA but not genomic rearrangements of other tyrosine kinases.
La Starza R; Specchia G; Cuneo A; Beacci D; Nozzoli C; Luciano L; Aventin A; Sambani C; Testoni N; Foppoli M; Invernizzi R; Marynen P; Martelli MF; Mecucci C
Haematologica; 2005 May; 90(5):596-601. PubMed ID: 15921374
[TBL] [Abstract][Full Text] [Related]
37. Lung cancer cell lines harboring MET gene amplification are dependent on Met for growth and survival.
Lutterbach B; Zeng Q; Davis LJ; Hatch H; Hang G; Kohl NE; Gibbs JB; Pan BS
Cancer Res; 2007 Mar; 67(5):2081-8. PubMed ID: 17332337
[TBL] [Abstract][Full Text] [Related]
38. Molecular characterization of pediatric gastrointestinal stromal tumors.
Agaram NP; Laquaglia MP; Ustun B; Guo T; Wong GC; Socci ND; Maki RG; DeMatteo RP; Besmer P; Antonescu CR
Clin Cancer Res; 2008 May; 14(10):3204-15. PubMed ID: 18483389
[TBL] [Abstract][Full Text] [Related]
39. Mutation and copy number analysis of LNX1 and Numbl in nervous system tumors.
Blom T; Roselli A; Tanner M; Nupponen NN
Cancer Genet Cytogenet; 2008 Oct; 186(2):103-9. PubMed ID: 18940473
[TBL] [Abstract][Full Text] [Related]
40. Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancer.
Kim YH; Kwei KA; Girard L; Salari K; Kao J; Pacyna-Gengelbach M; Wang P; Hernandez-Boussard T; Gazdar AF; Petersen I; Minna JD; Pollack JR
Oncogene; 2010 Mar; 29(10):1421-30. PubMed ID: 19966867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]